Ladenburg Thalmann Financial Services’s Arcus Biosciences RCUS Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$8K	Hold	790	–	–	﹤0.01%	4593
2019 Q3	$7K	Hold	790	–	–	﹤0.01%	4547
2019 Q2	$6K	Hold	790	–	–	﹤0.01%	4655
2019 Q1	$10K	Hold	790	–	–	﹤0.01%	4373
2018 Q4	$9K	Hold	790	–	–	﹤0.01%	4349
2018 Q3	$11K	Hold	790	–	–	﹤0.01%	4246
2018 Q2	$12K	Hold	790	–	–	﹤0.01%	4144
2018 Q1	$12K	Buy	+790	New	+$13.2K	﹤0.01%	4144

Other funds holding RCUS

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ladenburg Thalmann Financial Services's RCUS Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Arcus Biosciences (RCUS) position steady in Q4 2019 at 790 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #4593.

Ladenburg Thalmann Financial Services first reported a position in RCUS in Q1 2018 and has held it in 8 quarters since. The position peaked at $12K in Q2 2018. 75 funds tracked by Wall St. Rank hold RCUS as of Q4 2019.

Ladenburg Thalmann Financial Services held 790 shares of Arcus Biosciences worth $8K as of Q4 2019.
Ladenburg Thalmann Financial Services left its Arcus Biosciences share count unchanged in Q4 2019.
Arcus Biosciences made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4593 holding.
Ladenburg Thalmann Financial Services first reported a position in Arcus Biosciences in Q1 2018 and has held it in 8 quarters since.
Ladenburg Thalmann Financial Services's Arcus Biosciences position peaked at $12K in Q2 2018.
75 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.